peptideone
← All peptides

IGF-1 LR3

Status unknown

IGF-1 LR3 is classified under igf & growth-factor peptides.

What the research says

Aggregated from the cited literature below. We summarize sources — we don't author claims.

IGF-1 LR3 (long R3 IGF-1; LR3 IGF-1) has been investigated in recombinant production and in multiple animal/research models, including fetal sheep studies and an in vitro rumen epithelium study. In expression research, human IGF-1 and LR3 IGF-1 were recombinantly produced as fusion proteins in Pichia pastoris and purified products were reported to show bioactivity in cell proliferation assays. In fetal sheep, studies reported variable effects on growth outcomes (including reports of no growth improvement in growth-restricted fetuses) and findings on insulin secretion/insulin concentrations, while other studies reported organ-specific growth effects and parallel expansion of coronary vasculature.

Mechanism (as reported)

Across the provided sources, mechanistic findings include reported effects on insulin secretion dynamics, and in vitro evidence that LR3-IGF-1 acutely stimulates Na+ transport across rumen epithelium mediated by Na+-H+ exchange (NHE). PMIDs: 37114757, 39679943, 22227200.

Key findings (each cites a source)

  • A study reported recombinant expression of human IGF-1 and long R3 IGF-1 (LR3 IGF-1) in the Pichia pastoris system using fusion with xylanase XynCDBFV, with reported production of bioactive purified proteins and higher heterologous expression via bioreactor fermentation. [PMID 37261455]
  • A fetal sheep study reported that a 1-week IGF-1 LR3 treatment administered to growth-restricted fetuses did not improve fetal growth outcomes and did not attenuate circulating insulin concentrations or fetal glucose-stimulated insulin secretion (GSIS), while reporting decreased circulating amino acids in the LR3 group. [PMID 39679943]
  • A follow-up fetal sheep study investigated an acute exposure window and reported that glucose-stimulated insulin secretion was reduced in vivo with an IGF-1 LR3 infusion, but insulin secretion from isolated fetal islets did not differ based on infusion condition at the time of islet collection. [PMID 37114757]
  • A study reported that infusion of an ovine (sheep) recombinant IGF-1 promoted organ-specific growth in fetal sheep, including increased organ growth of several listed organs and stimulated skeletal muscle myoblast proliferation (this source compares the broader concept of IGF-1 analog effects and addresses limitations with LR3 IGF-1). [PMID 36091374]
  • A study in near-term fetal sheep reported that IGF-1 (LR3) treatment was associated with preserved coronary conductance per gram basis and that relationships between coronary flow and blood oxygen content were similar between IGF-1-treated and control groups, concluding that myocardial growth accompanied appropriate coronary vasculature expansion and function. [PMID 32573852]
  • A study reported that in vitro exposure of hay-fed sheep rumen epithelium to serosally applied LR3-IGF-1 acutely stimulated mucosal-to-serosal Na+ flux and net Na+ flux, with inhibition by amiloride and additional findings indicating increased pH(i) recovery rate consistent with increased Na+-H+ exchange activity. [PMID 22227200]
  • A study reported that a 1-week infusion of LR3 IGF-1 into late gestation fetal sheep increased the weight of some fetal organs but did not show statistically different fetal weights overall, and reported similar uterine/umbilical blood flow and similar umbilical uptake rates for glucose, lactate, and oxygen, while reporting lower umbilical amino acid uptake rates and lower fetal concentrations of multiple amino acids. [PMID 33427051]
  • A study reported a decellularized plant-based nerve conduit with controlled IGF-1 LR3 release, reporting improved axonal regeneration and comparable performance to autologous nerve grafts in a rat sciatic nerve defect model, and stated that the conduit did not induce systemic toxicity. [PMID 41015370]

Independent test grades

No independent third-party test data is available for IGF-1 LR3 yet. Our test grades are aggregated from Finnrick, which independently tests a subset of research peptides — many approved drugs and newer or niche compounds aren't covered.

Research literature (8)

Consolidated from PubMed — each links to the original record.

FAQ

What is IGF-1 LR3?
IGF-1 LR3 is classified under igf & growth-factor peptides. Research goals associated with it include gh axis support, body composition & muscle.
Is IGF-1 LR3 FDA-approved?
The regulatory status of IGF-1 LR3 is not established in our sources.
What does the research on IGF-1 LR3 say?
peptideone aggregates 8 references from PubMed for IGF-1 LR3. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.
Aggregated from public sources, with attribution. Not medical advice; compounds discussed are not approved for human consumption. Last updated 2026-06-15.